BR112015010271A2 - produto de comicronização, composição farmacêutica e seus usos - Google Patents
produto de comicronização, composição farmacêutica e seus usosInfo
- Publication number
- BR112015010271A2 BR112015010271A2 BR112015010271A BR112015010271A BR112015010271A2 BR 112015010271 A2 BR112015010271 A2 BR 112015010271A2 BR 112015010271 A BR112015010271 A BR 112015010271A BR 112015010271 A BR112015010271 A BR 112015010271A BR 112015010271 A2 BR112015010271 A2 BR 112015010271A2
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical composition
- comicronization
- product
- comicronization product
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1260603A FR2997627B1 (fr) | 2012-11-08 | 2012-11-08 | Produit de co-micronisation comprenant de l'ulipristal acetate |
PCT/FR2013/052670 WO2014072646A1 (fr) | 2012-11-08 | 2013-11-07 | Produit de co-micronisation comprenant de l'ulipristal acetate |
Publications (3)
Publication Number | Publication Date |
---|---|
BR112015010271A2 true BR112015010271A2 (pt) | 2017-07-11 |
BR112015010271A8 BR112015010271A8 (pt) | 2019-10-01 |
BR112015010271B1 BR112015010271B1 (pt) | 2020-04-22 |
Family
ID=47878175
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112015010271A BR112015010271B1 (pt) | 2012-11-08 | 2013-11-07 | produto de comicronização, processo para o preparo de um produto de comicronização, composição farmacêutica e seus usos |
Country Status (30)
Country | Link |
---|---|
US (2) | US9610293B2 (pt) |
EP (1) | EP2916871B1 (pt) |
JP (1) | JP2015536968A (pt) |
KR (1) | KR20150093170A (pt) |
CN (1) | CN104902928B (pt) |
AR (1) | AR093402A1 (pt) |
AU (1) | AU2013343320B2 (pt) |
BR (1) | BR112015010271B1 (pt) |
CA (1) | CA2890272A1 (pt) |
CR (1) | CR20150297A (pt) |
CY (1) | CY1119542T1 (pt) |
DK (1) | DK2916871T3 (pt) |
EA (1) | EA027641B1 (pt) |
EC (1) | ECSP15022442A (pt) |
ES (1) | ES2606307T3 (pt) |
FR (1) | FR2997627B1 (pt) |
GE (1) | GEP201706637B (pt) |
HR (1) | HRP20161624T1 (pt) |
HU (1) | HUE031911T2 (pt) |
LT (1) | LT2916871T (pt) |
MD (1) | MD4563C1 (pt) |
MX (1) | MX363699B (pt) |
PL (1) | PL2916871T3 (pt) |
PT (1) | PT2916871T (pt) |
RS (1) | RS55429B1 (pt) |
SI (1) | SI2916871T1 (pt) |
SM (1) | SMT201600445B (pt) |
TW (1) | TWI617325B (pt) |
UA (1) | UA117465C2 (pt) |
WO (1) | WO2014072646A1 (pt) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2997627B1 (fr) * | 2012-11-08 | 2015-01-16 | Hra Pharma Lab | Produit de co-micronisation comprenant de l'ulipristal acetate |
CN103923154B (zh) * | 2013-01-16 | 2017-09-26 | 杭州容立医药科技有限公司 | 醋酸乌利司他的共晶及制备方法 |
CN105663140A (zh) * | 2014-11-21 | 2016-06-15 | 四川海思科制药有限公司 | 一种含醋酸乌利司他的药物组合物及其制备方法 |
CN104865215A (zh) * | 2015-05-16 | 2015-08-26 | 南京海纳医药科技有限公司 | 一种醋酸乌利司他片剂及其溶出度测定方法 |
CN105919150A (zh) * | 2016-05-12 | 2016-09-07 | 高洁珺 | 一种代替压片工艺中化工添加剂的方法 |
CN106265533A (zh) * | 2016-10-10 | 2017-01-04 | 朱隆娅 | 一种阿德呋啉颗粒剂及其制备方法 |
FR3060389B1 (fr) | 2016-12-20 | 2019-05-31 | Laboratoire Hra-Pharma | Comprime enrobe comprenant de l'ulipristal acetate ou un de ses metabolites |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2627696B1 (fr) * | 1988-02-26 | 1991-09-13 | Fournier Innovation Synergie | Nouvelle forme galenique du fenofibrate |
US4954490A (en) | 1988-06-23 | 1990-09-04 | Research Triangle Institute | 11 β-substituted progesterone analogs |
GB9608719D0 (en) | 1996-04-26 | 1996-07-03 | Scherer Ltd R P | Pharmaceutical compositions |
FR2757397B1 (fr) * | 1996-12-23 | 1999-03-05 | Mazal Pharma | Composition pharmaceutique a base de rheine ou de diacerheine a biodisponibilite amelioree |
IL127129A (en) * | 1998-11-18 | 2004-06-01 | Ferring Bv | Method for preparation of progesterone tablets for vaginal delivery and tablets so prepared |
FR2821555B1 (fr) | 2001-03-01 | 2003-05-16 | Besins Int Lab | Progestatif co-micronise avec un tensioactif, composition pharmaceutique le comprenant, leurs procedes de fabrication et leurs utilisations |
FR2841138B1 (fr) * | 2002-06-25 | 2005-02-25 | Cll Pharma | Composition pharmaceutique solide contenant un principe actif lipophile, son procede de preparation |
ES2212912B1 (es) * | 2003-01-22 | 2005-10-01 | Crystal Pharma, S.A. | Procedimiento para la obtencion de 17alfa-acetoxi-11beta-(4-n,n-dimetilaminofenil)-19-norpregna-4,9-dien-3,20-diona. |
MX2007000273A (es) | 2004-07-09 | 2007-05-21 | Population Council Inc | Composiciones de liberacion sostenida que contiene moduladores del receptor de progesterona. |
WO2008037044A1 (en) | 2006-09-27 | 2008-04-03 | Medley S.A. Indústria Farmacêutica | Oxcarbazepine-containing oral formulation and a process to obtain the same |
ES2531929T3 (es) | 2006-12-20 | 2015-03-20 | Teva Women's Health, Inc. | Formas de dosificación solidas que se disgregan en la boca que comprenden progestina y métodos para hacer y usar las mismas |
JP2010514793A (ja) * | 2006-12-28 | 2010-05-06 | レプロス セラピューティクス インコーポレイティド | 抗プロゲスチンのバイオアベイラビリティを改善するための方法および製剤 |
WO2009067557A1 (en) * | 2007-11-19 | 2009-05-28 | Teva Pharmaceutical Industries Ltd. | Deferasirox pharmaceutical compositions |
US8299050B2 (en) | 2008-01-29 | 2012-10-30 | Laboratoire Hra-Pharma | Method for treating uterine fibroids |
US8512745B2 (en) * | 2008-12-08 | 2013-08-20 | Laboratoire Hra Pharma | Ulipristal acetate tablets |
CN102395373A (zh) | 2009-04-14 | 2012-03-28 | Hra医药实验室 | 按需避孕方法 |
EP2471537A1 (en) * | 2010-12-30 | 2012-07-04 | PregLem S.A. | Treatment of pain associated with dislocation of basal endometrium |
FR2997627B1 (fr) * | 2012-11-08 | 2015-01-16 | Hra Pharma Lab | Produit de co-micronisation comprenant de l'ulipristal acetate |
-
2012
- 2012-11-08 FR FR1260603A patent/FR2997627B1/fr not_active Expired - Fee Related
-
2013
- 2013-07-11 UA UAA201505665A patent/UA117465C2/uk unknown
- 2013-11-07 HU HUE13801639A patent/HUE031911T2/en unknown
- 2013-11-07 DK DK13801639.9T patent/DK2916871T3/da active
- 2013-11-07 PL PL13801639T patent/PL2916871T3/pl unknown
- 2013-11-07 GE GEAP201313847A patent/GEP201706637B/en unknown
- 2013-11-07 WO PCT/FR2013/052670 patent/WO2014072646A1/fr active Application Filing
- 2013-11-07 LT LTEP13801639.9T patent/LT2916871T/lt unknown
- 2013-11-07 AU AU2013343320A patent/AU2013343320B2/en not_active Ceased
- 2013-11-07 MX MX2015005762A patent/MX363699B/es unknown
- 2013-11-07 CN CN201380058466.0A patent/CN104902928B/zh not_active Expired - Fee Related
- 2013-11-07 PT PT138016399T patent/PT2916871T/pt unknown
- 2013-11-07 EA EA201500513A patent/EA027641B1/ru not_active IP Right Cessation
- 2013-11-07 BR BR112015010271A patent/BR112015010271B1/pt not_active IP Right Cessation
- 2013-11-07 CA CA2890272A patent/CA2890272A1/fr not_active Abandoned
- 2013-11-07 EP EP13801639.9A patent/EP2916871B1/fr active Active
- 2013-11-07 AR ARP130104089A patent/AR093402A1/es unknown
- 2013-11-07 KR KR1020157015210A patent/KR20150093170A/ko not_active Application Discontinuation
- 2013-11-07 RS RS20161080A patent/RS55429B1/sr unknown
- 2013-11-07 MD MDA20150053A patent/MD4563C1/ro not_active IP Right Cessation
- 2013-11-07 SI SI201330409A patent/SI2916871T1/sl unknown
- 2013-11-07 JP JP2015541214A patent/JP2015536968A/ja active Pending
- 2013-11-07 US US14/441,027 patent/US9610293B2/en not_active Expired - Fee Related
- 2013-11-07 ES ES13801639.9T patent/ES2606307T3/es active Active
- 2013-11-08 TW TW102140765A patent/TWI617325B/zh not_active IP Right Cessation
-
2015
- 2015-06-05 CR CR20150297A patent/CR20150297A/es unknown
- 2015-06-05 EC ECIEPI201522442A patent/ECSP15022442A/es unknown
-
2016
- 2016-11-29 CY CY20161101236T patent/CY1119542T1/el unknown
- 2016-12-02 HR HRP20161624TT patent/HRP20161624T1/hr unknown
- 2016-12-07 SM SM201600445T patent/SMT201600445B/it unknown
-
2017
- 2017-02-16 US US15/434,650 patent/US20170157146A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL285390A (en) | Arylquinazolines, their preparation and pharmaceutical preparations containing them | |
BR112015002738A2 (pt) | composto , e , composição farmacêutica | |
DK3181122T3 (da) | Farmaceutisk dasatinib-sammensætning | |
IL237839A0 (en) | History of hydropyrrolopyrrole, their preparation and pharmaceutical preparations containing them | |
IL235414A (en) | The history of pyrolotriazinone, their preparation and their pharmaceutical preparations | |
BR112014010290A2 (pt) | composição farmacêutica, métodos, composições e usos | |
BR112015003259A2 (pt) | composto, composição farmacêutica, e, composição de vacina. | |
BR112015009718A2 (pt) | composição de matéria e artigo. | |
HK1222563A1 (zh) | 藥物組合物、製備及其用途 | |
IL236057B (en) | History of 4,2,1-triazine-6-carboxamide and pharmaceutical preparations containing them | |
BR112015010271A2 (pt) | produto de comicronização, composição farmacêutica e seus usos | |
BR112015002824A2 (pt) | composto, uso de um composto, composição farmacêutica, e, produto farmacêutico de combinação. | |
DK2897594T3 (da) | Farmaceutisk sammensætning | |
IL233602A (en) | The history of benzamide, their preparation and their pharmaceutical preparations | |
BR112015009546A2 (pt) | compostos e seus processos de preparação, composições farmacêuticas e misturas ou associações farmacêuticas | |
CL2014003283A1 (es) | Formulación farmacéutica. | |
IL246406A0 (en) | History of imidazopyrazinone, their preparation and pharmaceutical preparations containing them | |
IL239054B (en) | History of azaquinazoline carboxamide, their preparation and pharmaceutical preparations containing them | |
BR112015010797A2 (pt) | compostos aniônicos substituídos, e, composição farmacêutica | |
IL238060B (en) | 2-aminopyridine derivatives, their preparation and pharmaceutical compositions containing them | |
IL246298A0 (en) | History of piperidine, their preparation and pharmaceutical preparations containing them | |
IL243982A0 (en) | History of piperidine urea, their preparation and pharmaceutical preparations containing them | |
BR112016027383A2 (pt) | Derivados de naftiridinadiona, seus usos, composição farmacêutica e combinação | |
BR112015002979A2 (pt) | forma cristalina, e, composição farmacêutica | |
BR112014032501A2 (pt) | composto, e, composição farmacêutica. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 07/11/2013, OBSERVADAS AS CONDICOES LEGAIS. |
|
B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 8A ANUIDADE. |
|
B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2643 DE 31-08-2021 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |